WallStSmart
MLYS

Mineralys Therapeutics, Inc. Common Stock

NASDAQ: MLYS · HEALTHCARE · BIOTECHNOLOGY

$25.56
-1.27% today

Updated 2026-04-29

Market cap
$2.11B
P/E ratio
P/S ratio
EPS (TTM)
$-2.29
Dividend yield
52W range
$13 – $48
Volume
1.2M

Mineralys Therapeutics, Inc. Common Stock (MLYS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+26.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+59.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-7.0%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.40+57.4%$25.02$23.28-7.0%
2025-11-11$-0.52+18.8%$44.50$47.33+6.4%
2025-08-12$-0.66+10.8%$13.19$13.56+2.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.94$-0.40+57.4%
2025-09-30$-0.64$-0.52+18.8%
2025-06-30$-0.74$-0.66+10.8%
2025-03-31$-0.98$-0.79+19.4%
2024-12-31$-1.08$-0.98+9.3%$34000.00
2024-09-30$-0.83$-1.13-36.1%
2024-06-30$-0.70$-0.83-18.6%
2024-03-31$-0.67$-0.70-4.5%
2023-12-31$-0.82$-0.61+25.6%
2023-09-30$-0.76$-0.57+25.0%
2023-06-30$-0.72$-0.31+56.9%

Frequently asked questions

Has Mineralys Therapeutics, Inc. Common Stock beaten earnings estimates?
Mineralys Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +26.6% over the last 4 quarters.
How does MLYS stock react to earnings?
MLYS stock has moved an average of +0.7% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.